These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9370387)

  • 1. Calcium antagonism abolishes the antipressor action of vasopressin (V1) receptor antagonism.
    Bakris GL; Kusmirek SL; Smith AC; Gavras I; Gavras H
    Am J Hypertens; 1997 Oct; 10(10 Pt 1):1153-8. PubMed ID: 9370387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunted blood pressure response to central sympathoinhibition in normotensive blacks: increased importance of nonsympathetic factors in blood pressure maintenance in blacks.
    Lang CC; Stein CM; He HB; Belas FJ; Blair IA; Wood M; Wood AJ
    Hypertension; 1997 Aug; 30(2 Pt 1):157-62. PubMed ID: 9260974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vasopressin in essential hypertension: racial differences.
    Bakris G; Bursztyn M; Gavras I; Bresnahan M; Gavras H
    J Hypertens; 1997 May; 15(5):545-50. PubMed ID: 9170008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.
    Mitchell HC; Smith RD; Cutler RE; Sica D; Videen J; Thompsen-Bell S; Jones K; Bradley-Guidry C; Toto RD
    Am J Kidney Dis; 1997 Jun; 29(6):897-906. PubMed ID: 9186076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
    Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Rolls KA; Johnston CI
    Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap between whites and blacks in response to antihypertensive drugs.
    Sehgal AR
    Hypertension; 2004 Mar; 43(3):566-72. PubMed ID: 14757779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs.
    Liard JF
    Circ Res; 1986 May; 58(5):631-40. PubMed ID: 3754791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic response to vasopressin during V1-receptor antagonism in baroreflex-deficient subjects.
    Huch KM; Runyan KR; Wall BM; Gavras H; Cooke CR
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R156-63. PubMed ID: 7840317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salt and blood pressure responses to calcium antagonism in hypertensive patients.
    Weir MR; Hall PS; Behrens MT; Flack JM
    Hypertension; 1997 Sep; 30(3 Pt 1):422-7. PubMed ID: 9314427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the sympathetic nervous system in blood pressure maintenance and in the antihypertensive effects of calcium antagonists in spontaneously hypertensive rats.
    Lefèvre-Borg F; Mathias O; Cavero I
    Hypertension; 1988 Apr; 11(4):360-70. PubMed ID: 2451639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine vasopressin enhances sympathetic constriction through the V1 vasopressin receptor in human saphenous vein.
    Medina P; Acuña A; Martínez-León JB; Otero E; Vila JM; Aldasoro M; Lluch S
    Circulation; 1998 Mar; 97(9):865-70. PubMed ID: 9580082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.
    Weir MR; Chrysant SG; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Lewin AJ; Mennella RF; Kirkegaard LW; Hamilton JH; Weinberger MH; Weder AB
    Hypertension; 1998 May; 31(5):1088-96. PubMed ID: 9576119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.
    M'Buyamba-Kabangu JR; Tambwe M
    Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():389-94. PubMed ID: 1980202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural effects on renal blood flow during acute hypotension vary with antihypertensive drugs.
    Takishita S; Muratani H; Kawazoe N; Kimura Y; Tozawa M; Fukiyama K
    Hypertension; 1994 Jan; 23(1 Suppl):I97-101. PubMed ID: 8282384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between AVP and sympathetic system in subtotal nephrectomy-saline hypertension: role of alpha and V1 receptors.
    Ozaykan B; Doğan A
    J Auton Nerv Syst; 2000 Jan; 78(2-3):165-71. PubMed ID: 10789696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
    Kawano Y; Makino Y; Okuda N; Takishita S; Omae T
    Blood Press Monit; 2000 Jun; 5(3):181-5. PubMed ID: 10915232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vasopressin V1-receptor blockade during acute and sustained hypovolemic hypotension.
    Wall BM; Huch KM; Runyan KR; Williams HH; Gavras H; Cooke CR
    Am J Physiol; 1996 Feb; 270(2 Pt 2):R356-64. PubMed ID: 8779866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of systemic neuropeptide Y release after carbachol administration into the posterior hypothalamic nucleus.
    Martin JR
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):447-57. PubMed ID: 8877593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Materson BJ; Reda DJ; Cushman WC; Massie BM; Freis ED; Kochar MS; Hamburger RJ; Fye C; Lakshman R; Gottdiener J
    N Engl J Med; 1993 Apr; 328(13):914-21. PubMed ID: 8446138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.